Purchase Order 75N95021P00227
Award Date
5/11/21
Potential Completion Date
11/9/21
Potential Value
$131K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Brainxell, Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Madison, WI 53711, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $100,000 firm fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Brainxell, Inc. to provide human cortical glutamatergic neurons derived from induced pluripotent stem cells (iPSCs). The neurons will be used by NCATS' Therapeutics for Rare and Neglected Diseases (TRND) program to study the pathophysiology of NGLY1 deficiency, a rare multi-system disease, and perform high-throughput...
This federal contract award to Brainxell, Inc. for $81,450.00 was issued by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to provide 40 vials of human midbrain dopaminergic cells derived from induced pluripotent stem cells (iPSCs) in two batches. The contract, which did not have a set-aside designation, was awarded on a firm fixed-price basis and included a 10% total price discount. Brainxell, a for-profit manufacturer...
This is a federal contract award to Brainxell, Inc., a for-profit manufacturer of human neuron cells and related services to support neurological disease research and drug discovery. The contract, valued at $18,725.00, was awarded by the National Institute on Drug Abuse, a part of the National Institutes of Health (NIH), under a small business set-aside. Brainxell will provide human neuron cells, customized neuron cell lines, and associated services to enable research on neuronal infectivity...
This $17,575 firm fixed price purchase order was awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency within the U.S. Department of Health and Human Services, to Brainxell, Inc., a for-profit manufacturer of human neuron cells. The contract is for the provision of CRISPR engineered cells to support neurological disease research and drug discovery. Brainxell has previously received other federal contract and grant awards from NIH institutes for projects...
The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, awarded a $100,000.00 firm fixed-price purchase order contract to Brainxell, Inc., a for-profit manufacturer of human neuron cells. The contract is for the provision of human cortical glutamatergic neurons to support research on neurological disease and SARS-CoV-2 infectivity. Brainxell, as a prime contractor, has previously received grant awards from...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) awarded a $135,997 firm-fixed price purchase order to Fujifilm Cellular Dynamics, Inc. to provide induced pluripotent stem cell (iPSC)-derived human midbrain floorplate dopaminergic (iCell DopaNeurons) and glutamatergic (iCell GlutaNeurons) neurons. These fully differentiated neurons will be used in a 3D in vitro circuitry model to evaluate...
<p>This is a firm fixed-price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Xcell Science Incorporated. The contract, with a ceiling value of $15,000.00, is for the derivation of TAS custom neuronal stem cells from human induced pluripotent stem cells. The contract does not have a set-aside designation and was awarded on August 17, 2012, with a completion date of September 6, 2012.</p>
The National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), awarded a $86,251 firm-fixed-price purchase order to Fujifilm Cellular Dynamics, Inc. to provide cryopreserved human induced pluripotent stem cell (iPSC)-derived neurons and related supplements. This non-competitive, brand-name acquisition is intended to support neurotoxicity screening assays. The requirement includes iCell DopaNeurons, iCell GlutaNeurons, and other neuronal cell...
This is a firm-fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to PGI Holding Corporation, a for-profit subchapter S corporation. The contract, valued at $139,400.00, is for the engraftment of human induced pluripotent stem cell (iPSC) derived astrocytes into the forebrain of adult and neonatal wild type mice. The contract was awarded on a non-competitive basis under simplified acquisition...
The Department of Health and Human Services, National Institutes of Health, National Center for Advancing Translational Sciences awarded a $118,665 firm-fixed-price purchase order to Fujifilm Cellular Dynamics, Inc., a foreign-owned for-profit manufacturer, for the supply of induced pluripotent stem cell-derived human neurons and astrocytes. This award was made on a non-competitive basis to support the Antiviral Program for Pandemics' research into antivirals for neurotropic viruses,...